{"disease":{"id":"skin-lesions","name":"skin lesions"},"drugs":{"marketed":[{"drug_id":"tretinoin","indication_name":"Kaposi's Sarcoma Skin Lesions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retin-A","generic_name":"TRETINOIN","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor ROR-beta","drug_class":"Retinoid [EPC]","quality_score":58,"revenue":null,"mechanism":"Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation."},{"drug_id":"alitretinoin","indication_name":"Kaposi's Sarcoma Skin Lesions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Panretin","generic_name":"ALITRETINOIN","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Retinoic acid receptor beta","drug_class":"Retinoid [EPC]","quality_score":10,"revenue":null,"mechanism":"Panretin works by binding to retinoic acid receptors in the skin, which helps to slow down the growth of cancer cells."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07415291","title":"CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17625,"lead_sponsor_name":"Istanbul Training and Research Hospital","has_results":false},{"nct_id":"NCT04155203","title":"To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":657,"lead_sponsor_name":"Padagis LLC","has_results":true},{"nct_id":"NCT06823999","title":"Prevention and Treatment for Bruises in Patients With Ischemic Stroke","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Chiayi Christian Hospital","has_results":false},{"nct_id":"NCT06663241","title":"The Validation of New Photographic Technology for Assessing Skin Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Wright State University","has_results":false},{"nct_id":"NCT04913740","title":"Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic","phase":"NA","overall_status":"UNKNOWN","enrollment_count":170,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03542539","title":"Dermoscopy in Diagnosis of Pigmentary Skin Lesions","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03356769","title":"Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06731062","title":"Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Eurofarma Laboratorios S.A.","has_results":false},{"nct_id":"NCT06680856","title":"Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Ospedale Policlinico San Martino","has_results":false},{"nct_id":"NCT06752460","title":"Evaluation of the EF192B Protection Versus No Treatment","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Eurofarma Laboratorios S.A.","has_results":false},{"nct_id":"NCT04203745","title":"Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Candela Corporation","has_results":true},{"nct_id":"NCT07428941","title":"Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT05712551","title":"Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4,"lead_sponsor_name":"Herlev Hospital","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}